Neutron capture cross section measurements at the Japan Proton Accelerator Research Complex (J-PARC) have been pivotal in advancing our understanding of nuclear reactions that underpin both ...
Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...
Attendees celebrated the accomplishments of a 10-year collaboration leading to the first patients treated in 2025 The first clinical trial at the HUS BNCT facility is nearing completion HELSINKI and ...
IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences, in collaboration with Kyoto University and Principal Investigator Dr. Fuyuhiko Tamanoi, is pleased to announce groundbreaking preclinical results in ...
BOSTON & BIRMINGHAM, United Kingdom--(BUSINESS WIRE)--Neutron Therapeutics, a leading developer of accelerator-based neutron systems for targeted radiation therapy of solid tumors, today announced ...